ERRATUM

Area of Science:

• Cardiology
• Emergency Medicine
• Pharmacology

Context:

• The original article provided consensus guidelines for managing atrial fibrillation in emergency departments.
• This erratum addresses specific inaccuracies identified post-publication.
• The consensus involved leading Spanish medical societies: SEMES, SEC, and SETH.

Purpose:

• To correct factual errors in the published article.
• To ensure accurate clinical guidance for emergency department management of atrial fibrillation.
• To provide updated figures and dosage information for rivaroxaban.

Summary:

• Figure 1 and Figure 3 from the original publication contained errors and have been replaced.
• The dosage for rivaroxaban in Table 1 has been corrected from 20 mg/12 h to 20 mg/24 h.
• These corrections pertain to the management of atrial fibrillation in emergency settings.

Impact:

• Ensures healthcare providers have access to accurate information for treating atrial fibrillation.
• Improves patient safety by correcting medication dosage errors.
• Maintains the integrity and reliability of clinical practice guidelines.